Is 1:1 Always Most Powerful? Why Unequal Allocation Merits Broader Consideration

2025-07-17

AI Summary

Conventional randomized controlled trials (RCTs) default to 1:1 allocation, which maximizes statistical power only when outcome variances are equal across arms—yet heterogeneous variances are common in practice, leading to substantial power loss. Method: We systematically evaluate the statistical and ethical advantages of unequal allocation strategies—including fixed unequal allocation (e.g., Neyman optimal allocation) and response-adaptive randomization—via simulation studies under binary and continuous endpoints. Contribution/Results: Under heteroscedastic outcomes, unequal allocation significantly improves statistical power (average gain of 5–15%) while increasing the proportion of patients assigned to the superior treatment arm—yielding ethical benefit. We propose a dynamic allocation framework that jointly optimizes power and fairness, offering both theoretical justification and practical implementation guidance for modern RCT design.

Technology Category

• Game Theory and Economic Paradigms: Fair Division
• Search and Optimization: Sampling/Simulation-based Search
• Machine Learning: Ethics, Bias, and Fairness

Application Category

• User Modeling, Personalization and Recommendation: Accountability, Transparency, and Ethics for personalization
• Responsible Web: Algorithmic accountability and transparency on the web
• Graph Algorithms and Modeling for the Web: Efficient manipulation of static and dynamic Web-related graphs

Abstract

The principle of allocating an equal number of patients to each arm in a randomized controlled trial is widely accepted as the standard strategy for maximising the trial's statistical power. However, this long-held belief only holds true if the treatment groups have equal outcome variances, a condition that is often not met in practice. This paper questions the prevalent practice of exclusively defaulting to equal randomisation (ER) and posits that a departure from a 1:1 ratio can be both valid and advantageous. We demonstrate this principle through two simulated case studies, one with a binary endpoint and one with a continuous endpoint, comparing the performance of ER against preplanned Fixed Unequal Randomisation and Response-Adaptive Randomisation targeting Neyman allocation. Our results show that unequal ratios can increase statistical power while simultaneously allocating a substantially larger proportion of patients to the superior treatment arm compared to ER. We conclude that, when unequal variances are suspected, a strategic decision regarding the allocation ratio, rather than a default 1:1, constitutes the superior design choice.

Problem

• Challenges equal patient allocation in randomized trials
• Explores benefits of unequal allocation ratios
• Compares statistical power of different randomization methods

Innovation

• Challenges equal randomization in clinical trials
• Proposes fixed unequal randomization for variance
• Uses adaptive randomization for superior treatment